RT Journal Article
SR Electronic
T1 Why is chest CT important for early diagnosis of COVID-19? Prevalence matters
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.30.20047985
DO 10.1101/2020.03.30.20047985
A1 Antonio Esposito
A1 Anna Palmisano
A1 Giulia Maria Scotti
A1 Marco J. Morelli
A1 Davide Vignale
A1 Francesco De Cobelli
A1 Giovanni Tonon
A1 Carlo Tacchetti
YR 2020
UL http://medrxiv.org/content/early/2020/04/01/2020.03.30.20047985.abstract
AB SARS-CoV-2 viral infection is a global pandemic disease (COVID-19). Reaching a swift, reliable diagnosis of COVID-19 in the emergency departments is imperative to direct patients to proper care and to prevent disease dissemination. COVID-19 diagnosis is based on the identification of viral RNA through RT-PCR from oral-nasopharyngeal swabs, which however presents suboptimal sensitivity and may require several hours in overstressed laboratories. These drawbacks have called for an additional, complementary first line approach. CT is the gold standard method for the detection of interstitial pneumonia, a hallmark feature of COVID-19, often present in the asymptomatic stage of the disease. Here, we show that CT scan presents a sensitivity of 95.48% (std.err=0.35%), vastly outperforming RT-PCR. Additionally, as diagnostic accuracy is influenced by disease prevalence, we argue that predictive values provide a more precise measure of CT reliability in the current pandemics. We generated a model showing that CT scan is endowed with a high negative predictive value (> 90%) and positive predictive value (69 - 84%), for the range of prevalence seen in countries with rampant dissemination. We conclude that CT is an expedite and reliable diagnostic tool to support first line triage of suspect COVID-19 patients in areas where the diffusion of the virus is widespread.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially supported by the Italian Ministry of Health with 5x1000 funds and by OSR Program COVID-19.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are included in the embedded Table 1.